What Is The Neuroendocrine Carcinoma Of The Colon

Mar 6
07:35

2009

Paul Abbey

Paul Abbey

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

The colon is a major part of the large intestine, whereas a carcinoma is a malignant cancer that crops up from epithelial cells.

mediaimage

One of the more agressive and worst types of cancer is neuroendocrine carcinoma of the colon. The most negative part about the disease is that more often than not it is detected late into the advanced stages when it is extremely hard to make treatments.

As the effects of neuroendocrine colon cancer take form only as the condition advances the survival rate of the patient diminishes. The tumors are mostly detected with distant metastases. In several surveys,What Is The Neuroendocrine Carcinoma Of The Colon Articles reports reveal that most of the cases of neuroendocrine cancer end with the death of the patient.

Although the possibilities of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the patient’s condition becomes worse than patients suffering from adenocarcinoma.

Research shows that the end results surrounding this form of cancer do not change with age, sex or tumor location. Though neuroendocrine colon carcinoma does depend on the stage of the tumor. The usual trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer will generally not experience  neuroendocrine colon cancer. But alternately in several cases, if the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

Unfortunately, medical science has few techniques to help patients with this cancer. Among the more popular methods that the doctors often use is immunohistochemical staining methods. a method which greatly helps the doctors to detect the seriousness of neuroendocrine colon cancer and really helps determine the suitable medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of said tumor with a monoclonal antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and the extent of damage on the patient’s health.

Neuroendocrine colon carcinoma is difficult to treat and in a certain study in which a number of patients suffered from this particular disease underwent examination and, an observation was made that the average survival rate surrounding this disease was in most cases, seven months. While in a predominant stage, the rates were as less as five months. Most cases were at first found to be as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery may not be a perfect or even viable treatment so surgery may not provide the patient with a proper cure. Therefore it becomes necessary to notice the presence of this disease quickly and administer the proper treatment.